PAPOLG expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.625180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.943840E-01
Normal-vs-Stage2
1.933440E-01
Normal-vs-Stage3
7.286000E-02
Normal-vs-Stage4
9.363600E-01
Stage1-vs-Stage2
7.835800E-01
Stage1-vs-Stage3
1.261840E-01
Stage1-vs-Stage4
1.723230E-01
Stage2-vs-Stage3
5.68119999999617E-05
Stage2-vs-Stage4
1.611150E-01
Stage3-vs-Stage4
3.113600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.509180E-01
Normal-vs-AfricanAmerican
7.658600E-01
Normal-vs-Asian
1.882140E-02
Caucasian-vs-AfricanAmerican
5.252600E-01
Caucasian-vs-Asian
6.730400E-02
AfricanAmerican-vs-Asian
2.121000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.600160E-01
Normal-vs-Female
1.785610E-01
Male-vs-Female
3.924600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.255950E-01
Normal-vs-Age(41-60Yrs)
4.643000E-01
Normal-vs-Age(61-80Yrs)
8.534300E-02
Normal-vs-Age(81-100Yrs)
7.840100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.630200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.416000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.150400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.021800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.167020E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.962800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.097500E-02
Normal-vs-Daily Drinker
8.218200E-02
Normal-vs-Weekly Drinker
1.869630E-01
Normal-vs-Occasional Drinker
1.513400E-01
Normal-vs-Social Drinker
4.756200E-01
Non Drinker-vs-Daily Drinker
9.572800E-01
Non Drinker-vs-Weekly Drinker
8.974800E-01
Non Drinker-vs-Occasional Drinker
1.347780E-01
Non Drinker-vs-Social Drinker
7.654100E-02
Daily Drinker-vs-Weekly Drinker
8.722600E-01
Daily Drinker-vs-Occasional Drinker
2.037800E-01
Daily Drinker-vs-Social Drinker
1.314810E-01
Weekly Drinker-vs-Occasional Drinker
3.876000E-01
Weekly Drinker-vs-Social Drinker
2.775600E-01
Occasional Drinker-vs-Social Drinker
5.901600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.284400E-02
Normal-vs-Grade 2
1.026030E-02
Normal-vs-Grade 3
1.317810E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.044590E-01
Grade 1-vs-Grade 3
9.025600E-02
Grade 1-vs-Grade 4
8.284400E-02
Grade 2-vs-Grade 3
6.543200E-01
Grade 2-vs-Grade 4
1.026030E-02
Grade 3-vs-Grade 4
1.317810E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.407410E-01
Normal-vs-NonDiabetic
1.118620E-01
Diabetic-vs-NonDiabetic
9.688400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.125700E-02
Normal-vs-NoPancreatitis
1.384220E-01
Pancreatitis-vs-NoPancreatitis
9.870200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.278400E-02
Normal-vs-N1
2.232800E-01
N0-vs-N1
2.042600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.694400E-02
Normal-vs-TP53-NonMutant
2.254600E-01
TP53-Mutant-vs-TP53-NonMutant
6.645200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
